Utilizing Biomarker Signature Pairs To Develop Gene Therapeutic Viral Delivery Platforms For Treating Prostate Cancer

Speaker

Portrait of Tamaro Hudson, PhD, MPHTamaro Hudson, PhD, MPH
Assistant Professor, Department of Pharmacology
Howard University
Health Research Specialist
Washington VA Medical Center
Washington, DC

 

 

 

Dr. Tamaro Hudson is currently an Assistant Professor at Howard University in the Department of Pharmacology and holds an appointment as a Health Research Specialist at the Washington VA Medical Center. Dr. Hudson received his Bachelor of Science from Iowa State University in Biology in 1994 and went on to receive a Master of Science in Preventive Medicine from Ohio State University in 2007. Afterwards, he received a PhD from Ohio State University in 2002 where he focused on evaluating the functional differences among isothiocyanates in the rat esophageal tumor model. Following his PhD, Dr. Hudson was selected to complete a prestigious Cancer Prevention Fellowship Program at the National Institute of Health, National Cancer Institute, where he focused on utilizing in vitro and in vivo cancer models to assess the biological activity of bioactive compounds on prostate cancer molecular pathways. Concurrently, he completed a Master of Public Health degree from George Washington University in 2003 where he focused on assessing the degree of agreement between a food frequency questionnaire and a 4-day food record as it related to dietary fiber intake. Upon completion of his MPH and Fellowship, he was recruited by Howard University Cancer Center in 2007 as an Assistant Professor.

Since joining the Howard faculty, Dr. Hudson has integrated his research focus by identifying novel signature biomarkers – that could have a significant impact on both the diagnosis and targeted treatment of prostate cancer – with the evaluation of new chemopreventive strategies, which have been evaluated in Phase I and Phase II clinical trials. Dr. Hudson received the first five-year VA-HBCU Research, Scientist, and Training grant that focuses on developing a biomarker-based risk prediction model for prostate cancer. Dr. Hudson serves on several Howard University committees and has many peer-reviewed publications. Dr. Hudson's research interests continue to expand as he tries to build collaborations across broad disciplines to make an impact in translational research.

About the Cancer Prevention and Control Colloquia Series

The Cancer Prevention and Control Colloquia Series features current research findings from guest researchers from a variety of research disciplines. Topics cover current challenges and methods used by investigators to address gaps, advance the field of cancer prevention and control, and promote the application of successful strategies.

Date and Time: 

Tue, 10/24/2017 - 11:00 - 12:00

Location: 

NCI Shady Grove Room 2W032/034

Speaker(s): 

Tamaro Hudson, PhD, MPH

Sponsor(s): 

Cancer Prevention Fellowship Program Colloquia lecture